Number of suitable patients: CDEC discussed the uncertainty in the number of people with reasonably significant to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some sufferers who are classified as owning moderate or reasonable illness may have a severe bleeding phenot… Read More